Toolkit for determination of dose-response relations, validation of radiobiological parameters and treatment plan optimization based on radiobiological measures

Technology in Cancer Research and Treatment

Volumn 9, Issue 5, 2010, Pages 523-537

  Mavroidis, Panayiotis ^a,b   Tzikas, Athanasios ^a   Papanikolaou, Nikos ^c   Lind, Bengt K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Dose response relations; Radiobiological parameters; Treatment plan optimization

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER PROGRAM; CONFIDENCE INTERVAL; DOSE RESPONSE; DOSIMETRY; FOLLOW UP; INTERMETHOD COMPARISON; PROCESS OPTIMIZATION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; RADIOSENSITIVITY; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; VALIDATION PROCESS;

EID: 78049310805     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303461000900511     Document Type: Article

References (44)

1. Brahme, A. Treatment optimization using physical and biological objective functions. Radiation Therapy Physics. Ed. Smith, A. (Berlin: Springer) 209-246 (1995).
2. Källman, P., Lind, B. K., Brahme, A. An algorithm for maximizing the probability of complication free tumor control in radiation therapy. Phys Med Biol 37, 871-890 (1992).
3. Mavroidis, P., Lind, B. K., Van Dijk, J., Koedooder, K., De Neve, W., De Wagter, C., Planskoy, B., Rosenwald, J. C., Proimos, B., Kappas, C., Claudia, D., Benassi, M., Chierego, G., Brahme, A. Comparison of conformal radiation therapy techniques within the dynamic radiotherapy project 'Dynarad'. Phys Med Biol 45, 2459-2481 (2000).
4. Emami, B., Lyman, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., Wesson, A. M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21, 109-122 (1991).
5. Ågren, A-K. Quantification of the response of heterogeneous tumors and organized normal tissues to fractionated radiotherapy. Ph.D. Thesis. Stockholm University (1995).
6. Mavroidis, P. Determination and use of radiobiological response parameters in radiation therapy optimization. Ph.D. Thesis. Karolinska Institutet (2001).
7. Eriksson, F., Gagliardi, G., Liendberg, A., Lax, I., Lee, C., Levitt, S., Lind, B., Rutqvist, L-E. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol 55, 153-62 (2000).
8. Gagliardi, G., Bjöhle, J., Lax, I., Ottolenghi, A., Eriksson, F., Liedberg, A., Lind, P., Rutqvist, L-E. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 46, 373-381 (2000).
9. Jackson, A., Ten Haken, R. K., Robertson, J. M., Kessler, M. L., Kutcher, G. J., Lawrence, T. S. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31, 883-891 (1995).
10. Mavroidis, P., Lind, B. K., Brahme, A. Biologically effective uniform dose (Dcombining double overline) for specification, report and comparison of dose response relations and treatment plans. Phys Med Biol 46, 2607-2630 (2001).
11. Mavroidis, P., Lind, B. K., Theodorou, K., Laurell, G., Fernberg, J. O., Lefkopoulos, D., Kappas, C., Brahme, A. Statistical methods for clinical verification of dose-response parameters related to esophageal stricture and AVM obliteration from radiotherapy. Phys Med Biol 49, 3797-3816 (2004).
12. Ferreira, B. C., Mavroidis, P., Adamus-Górka, M., Svensson, R., Lind, B. K. Impact of different dose-response parameters on biologically optimized IMRT in breast cancer. Phys Med Biol 53, 2733-2752 (2008).
13. Gagliardi, G. Modeling heart and lung complication data in radiation therapy of the breast. Ph.D. Thesis. Stockholm University (1998).
14. Levegrün, S., Jackson, A., Zelefsky, M. J., Venkatraman, E. S., Skwarchuk, M. W., Schlegel, W., Fuks, Z., Leibel, S. A., Ling, C. C. Risk group dependence of dose-response for biopsy outcome after three dimensional conformal radiation therapy of prostate cancer. Radiother Oncol 63, 11-26 (2002).
15. Mavroidis, P., Theodorou, K., Lefkopoulos, D., Nataf, F., Schlienger, M., Karlsson, B., Lax, I., Kappas, C., Lind, B. K., Brahme, A. Prediction of AVM obliteration after stereotactic radiotherapy using radiobiological modelling. Phys Med Biol 47, 2471-2494 (2002).
16. Brahme, A., Ågren, A-K. Optimal dose distribution for eradication of heterogeneous tumors. Acta Oncol 26, 377 (1987).
17. Källman, P., Ågren, A-K., Brahme, A. Tumor and normal tissue responses to fractionated non uniform dose delivery. Int J Radiat Biol 62, 249-262 (1992).
18. Thames, H. D. An "incomplete repair" model for survival after fractionated and continuous radiations. Int J Radiat Biol 47, 319-339 (1985).
19. Tucker, S. L., Thames, H. D., Taylor, J. M. G. How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Rad Res 124, 273-282 (1990).
20. Porter, E. H. The statistics of dose/cure relationships for irradiated tumors. Part I. Br J Radiol 53, 210-227 (1980).
21. Withers, H. R., Taylor, J. M. G., Maciejewski, B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 14, 751-759 (1988).
22. Lind, B. K., Mavroidis, P., Hyödynmaa, S., Kappas, C. Optimization of the dose level for a given treatment plan to maximize the complication free tumor cure. Acta Oncol 38, 787-798 (1999).
23. Burman, C., Kutcher, G. J., Emami, B., et al. Fitting of normal tissue tolerance data to an analytical function. Int J Radiat Oncol Biol Phys 21, 123-135 (1991).
24. Kutcher, G. J., Burman, C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 16, 1623-1630 (1989).
25. Kwa, S., Theuws, C., Wagendar, A., et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48, 61-69 (1998).
26. Lyman, J. T., Wolbarst, A. Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13, 103-109 (1987).
27. Jackson, A., Kutcher, G. J., Yorke, E. D. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform radiation. Med Phys 20, 613-625 (1993).
28. Adamus-Górka, M. Improved dose response modelling for normal tissue damage and therapy optimization. Ph.D. Thesis. Stockholm University (2008).
29. Brown, J. M. Management and significance of hypoxic cells. Annual meeting of ASTRO, Miami, Florida (1990).
30. Nilsson, J., Lind, B. K., Brahme, A. Radiation response of hypoxic and generally heterogeneous tissues Int J Radiat Biol 78, 389-405 (2002).
31. Rancati, T., Wennberg, B., Lind, P., Svane, G., Gagliardi, G. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models. Radiother Oncol 82, 308-316 (2007).
32. Mavroidis, P., Laurell, G., Kraepelien, T., Fernberg, J-O., Lind, B. K., Brahme, A. Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol 42, 865-881 (2003).
33. Mavroidis, P., al-Abany, M., Helgason, A. R., Ågren-Cronqvist, A-K., Wersäll, P., Theodorou, K., Kappas, C., Lind, H., Lind, B. K., Steineck, G., Brahme, A. Dose-response relations for anal sphincter regarding faecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Strahlenther Onkol 181, 293-306 (2005).
34. Thames, H. D., Hendry, J. H. Radiation induced injury to tissues. Fractionation in radiotherapy. Ed. Thames, H. D., Hendry, J. H. (Philadelphia: Taylor & Francis) 1-21 (1987).
35. Bentzen, S. M., Baumann, M. The linear-quadratic model in clinical practice. Basic clinical radiobiology. Ed. Steel, G. G. (London: Arnold) 134-146 (2002).
36. Schilstra, C., Meertens, H. Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland. Int J Radiat Oncol Biol Phys 50, 147-158 (2001).
37. Van Luijk, P., Delvigne, T. C., Schilstra, C., Schippers, J. M. Estimation of parameters of dose-volume models and their confidence limits. Phys Med Biol 48, 1863-1884 (2003).
38. Eadie, W. T., Drijard, D., James, F. E., Roos, M., Sadoulet, B. Statistical methods in experimental physics. CERN. (Amsterdam: North Holland) (1971).
39. Hanley, J. A., McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36 (1982).
40. Ågren, A-K., Brahme, A., Turesson, I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 19, 1077-1085 (1990). (Pubitemid 20345184)
41. Mavroidis, P., Lind, B. K. In response to 'Behind EUD'. Acta Oncol 48, 610-614 (2009).
42. Vaarkamp, J., Zhu, Y. Comments on 'Validity of the EUD and TCP concepts as reliable dose indicators'. Phys Med Biol 45, L11-L16 (2000).
43. Herring, D. F. Methods for extracting dose-response curves from radiation therapy data, I: A unified approach. Int J Radiat Oncol Biol Phys 6, 225-232 (1980).
44. Venkatraman, E. S., Begg, C. A distribution-free procedure for comparing receiver operating characteristic curves from a paired experiment. Biometrika 83, 835-848 (1996).